Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech

Joseph La Barge

Dave Greenwald’s days as acting CEO of Apertura Gene Therapy are over as Joseph La Barge steps in to lead the biotech, which just launched in April.

Peer Review had been wondering about La Barge’s next…